Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2018

01-07-2018 | Original Article

Fever of unknown origin (FUO): CMV infectious mononucleosis or lymphoma?

Authors: Burke A. Cunha, Karishma Chawla

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2018

Login to get access

Abstract

Fever of unknown origin (FUO) refers to fevers of > 101 °F that persist for > 3 weeks and remain undiagnosed after a focused inpatient or outpatient workup. FUO may be due to infectious, malignant/neoplastic, rheumatic/inflammatory, or miscellaneous disorders. The FUO category determines the focus of the diagnostic workup. In the case presented of an FUO in a young woman, there were clinical findings of both CMV infectious mononucleosis or a lymphoma, e.g., highly elevated ESR, elevated ferritin levels, and elevated ACE level, β-2 microglobulins. The indium scan showed intense splenic uptake. Lymph node biopsy, PET scan, and flow cytometry were negative for lymphoma. CMV infectious mononucleosis was the diagnosis, and she made a slow recovery.
Literature
1.
go back to reference Cunha BA (2007) Fever of unknown origin: clinical overview and perspective. In: Cunha BA (ed) Fever of unknown origin. Informa Healthcare, New York, pp 1–8CrossRef Cunha BA (2007) Fever of unknown origin: clinical overview and perspective. In: Cunha BA (ed) Fever of unknown origin. Informa Healthcare, New York, pp 1–8CrossRef
2.
go back to reference Cunha BA (2007) Fever of unknown origin: focused diagnostic approach based on clinical clues from the history, physical examination and laboratory tests. Infect Dis Clin N Am 21:1137–1187CrossRef Cunha BA (2007) Fever of unknown origin: focused diagnostic approach based on clinical clues from the history, physical examination and laboratory tests. Infect Dis Clin N Am 21:1137–1187CrossRef
3.
go back to reference Carlstrom G, Alden J, Belfrage S, Hedenström G, Holmberg L, Nordbring F, Sterner G (1968) Acquired cytomegalovirus infection. British Med J 2:521–525CrossRef Carlstrom G, Alden J, Belfrage S, Hedenström G, Holmberg L, Nordbring F, Sterner G (1968) Acquired cytomegalovirus infection. British Med J 2:521–525CrossRef
4.
go back to reference Cohen JI, Corey GR (1985) Cytomegalovirus infection in the normal host. Medicine (Baltimore) 64:100–114CrossRef Cohen JI, Corey GR (1985) Cytomegalovirus infection in the normal host. Medicine (Baltimore) 64:100–114CrossRef
5.
go back to reference Cunha BA (2010) Cytomegalovirus pneumonia: community-acquired pneumonia in immunocompetent hosts. Infect Dis Clin N Amer 24:147–158CrossRef Cunha BA (2010) Cytomegalovirus pneumonia: community-acquired pneumonia in immunocompetent hosts. Infect Dis Clin N Amer 24:147–158CrossRef
6.
go back to reference Cunha BA, Hage JE, Nouri Y (2012) Fever of unknown origin (FUO) in an immunocompetent adult due to cytomegalovirus (CMV) with polyclonal gammopathy. Infection 40:327–330CrossRefPubMed Cunha BA, Hage JE, Nouri Y (2012) Fever of unknown origin (FUO) in an immunocompetent adult due to cytomegalovirus (CMV) with polyclonal gammopathy. Infection 40:327–330CrossRefPubMed
7.
go back to reference Cunha BA, Sivarajah T, Jimada I (2017) Sarcoidosis with fever and splenic infarct due to CMV or lymphoma? Heart Lung 46:394–396CrossRefPubMed Cunha BA, Sivarajah T, Jimada I (2017) Sarcoidosis with fever and splenic infarct due to CMV or lymphoma? Heart Lung 46:394–396CrossRefPubMed
8.
go back to reference Eddelston M, Peacock S, Juniper M, Warrell DA (1997) Severe cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 24:52–56CrossRef Eddelston M, Peacock S, Juniper M, Warrell DA (1997) Severe cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 24:52–56CrossRef
9.
go back to reference Cunha CB (2017) Infectious disease differential diagnosis. In: Cunha BA (ed) Antibiotic Essentials, 15th edn. Jay Pee Medical Publishers, New Delhi Cunha CB (2017) Infectious disease differential diagnosis. In: Cunha BA (ed) Antibiotic Essentials, 15th edn. Jay Pee Medical Publishers, New Delhi
10.
go back to reference Ho M (1991) Cytomegalovirus: biology and infection, 2nd edn. Plenum, New YorkCrossRef Ho M (1991) Cytomegalovirus: biology and infection, 2nd edn. Plenum, New YorkCrossRef
11.
go back to reference Horwitz CA, Henle W, Henle G, Snover D, Rudnick H, Balfour HH Jr et al (1986) Clinical and laboratory evaluation of cytomegalovirus- induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore) 65:124–134CrossRef Horwitz CA, Henle W, Henle G, Snover D, Rudnick H, Balfour HH Jr et al (1986) Clinical and laboratory evaluation of cytomegalovirus- induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore) 65:124–134CrossRef
12.
go back to reference Horowitz CA, Henle W, Henle G (1979) Diagnostic aspects of the cytomegalovirus mononucleosis syndrome in previously healthy persons. Postgrad Med 66:153–158CrossRef Horowitz CA, Henle W, Henle G (1979) Diagnostic aspects of the cytomegalovirus mononucleosis syndrome in previously healthy persons. Postgrad Med 66:153–158CrossRef
13.
go back to reference Manfredi R, Calza L, Chiodo F (2006) Primary cytomegalovirus infection in otherwise healthy adults with fever of unknown origin: a 3-year prospective survey. Infection 34:87–90CrossRefPubMed Manfredi R, Calza L, Chiodo F (2006) Primary cytomegalovirus infection in otherwise healthy adults with fever of unknown origin: a 3-year prospective survey. Infection 34:87–90CrossRefPubMed
14.
go back to reference Nolan N, Halai U, Regunath H, Smith LP, Rojas-Moreno C, Salzer W (2017) Primary cytomegalovirus infection in immunocompetent adults in the United States—a case series. ID Cases 10:123–126PubMedPubMedCentral Nolan N, Halai U, Regunath H, Smith LP, Rojas-Moreno C, Salzer W (2017) Primary cytomegalovirus infection in immunocompetent adults in the United States—a case series. ID Cases 10:123–126PubMedPubMedCentral
15.
go back to reference Pass RF (2001) Cytomegalovirus. In: Knipe DM, Howley PM (eds) Field virology, vol 2, 4th edn. Lippincott, Williams & Wilkins, Philadelphia, pp 2675–2705 Pass RF (2001) Cytomegalovirus. In: Knipe DM, Howley PM (eds) Field virology, vol 2, 4th edn. Lippincott, Williams & Wilkins, Philadelphia, pp 2675–2705
16.
go back to reference Griffiths PD, Emery VC, Milne R (2009) Cytomegalovirus. In: Richman DD, Whitley RJ, Hayden FG (eds) Clinical virology, 3rd edn. ASM Press, Washington DC, pp 475–506 Griffiths PD, Emery VC, Milne R (2009) Cytomegalovirus. In: Richman DD, Whitley RJ, Hayden FG (eds) Clinical virology, 3rd edn. ASM Press, Washington DC, pp 475–506
17.
go back to reference Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME (2008) Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 5:47CrossRefPubMedPubMedCentral Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME (2008) Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 5:47CrossRefPubMedPubMedCentral
18.
19.
go back to reference Sterner G, Agell BO, Wahren B, Espmark A (1970) Acquired cytomegalovirus infection in older children and adults. Scand J Infect Dis 2:95–103CrossRefPubMed Sterner G, Agell BO, Wahren B, Espmark A (1970) Acquired cytomegalovirus infection in older children and adults. Scand J Infect Dis 2:95–103CrossRefPubMed
20.
go back to reference Wreghit TG, Teare EL, Sule O, Devi R, Rice P (2003) Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 37:1603–1606CrossRef Wreghit TG, Teare EL, Sule O, Devi R, Rice P (2003) Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 37:1603–1606CrossRef
Metadata
Title
Fever of unknown origin (FUO): CMV infectious mononucleosis or lymphoma?
Authors
Burke A. Cunha
Karishma Chawla
Publication date
01-07-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3262-2

Other articles of this Issue 7/2018

European Journal of Clinical Microbiology & Infectious Diseases 7/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine